Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 2c; Boosts FY11 EPS Outlook

May 3, 2011 4:05 PM

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q1 EPS of $0.59, $0.02 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found